Search results
Shionogi secures licence for Maze’s Pompe disease treatment
Pharmaceutical Technology· 10 hours agoIn June 2023, Shionogi entered into a definitive agreement to acquire Qpex Biopharma for $140m....
The CDC issues a report about infections from stem-cell treatments in Mexico - ET HealthWorld
The Economic Times· 15 hours agoMexico City: The U.S. Centers for Disease Control and Prevention issued a report Thursday about...
Does Medicare Cover Wegovy?
Verywell Health· 4 hours agoWhat This Means For You If you have obesity or overweight and heart disease, the new Medicare coverage for Wegovy might offer you a valuable treatment...
Gall bladder stones: Early symptoms and complications one should know about - Times of India
The Times of India· 14 hours agoOne such silent threat is gallbladder stones, a condition that affects millions of people worldwide....
Four ways the vaccine rush will define infectious disease trends for CROs in 2024
Pharmaceutical Technology· 12 hours agoThe speed and flexibility required in clinical trials for COVID-19 set a new precedent for what can...
Kite and Arcellx prepare to launch Phase III multiple myeloma trial
Clinical Trials Arena· 12 hours agoIt will enrol RRMM patients who have undergone one to three treatments previously. It will enrol...
The New Seasonal Eating Breakthrough That Helps You Ditch The Weight-Gain Blame Game, Reverse...
First for Women· 12 hours agoCheck! “After having seen so many reversals of diabetes, we think it should be viewed as a...
World Lupus Day: Symptoms, Causes, Treatment - Know Complications That Arise Due To Lupus
Latest India News· 14 hours agoAn autoimmune disorder, lupus makes your body's immune system attack your own tissues and organs....
Embracing my ADHD in motherhood led me to deeper self-compassion
Motherly· 7 hours ago"We somehow believe if we just beat ourselves up enough, we can compartmentalize our mental health ...
Can-Fite receives FDA IND clearance for Phase IIb MASH treatment trial
Clinical Trials Arena· 10 hours ago“As we are already enrolling patients for this study, we hope that in the next few months, we will...